Nanoemulsion-templated long sustained polyelectrolyte (PE) nanocapsules (average size < 200 nm) loaded with Oil Red O and two cyanine-type photosensitizers: IR-786 and IR-780 were successfully fabricated by using the layer-by-layer (LbL) technique. All nanoproducts were subjected to in vitro release characteristics and analysis of selected control parameters, i.e., type of surfactant head group, characteristic release time and surfactant–polyelectrolyte interactions. Their properties were characterized by means of dynamic light scattering (DLS) compared with scanning electron microscopy (SEM) and atomic force microscopy (AFM). In our studies for construction of oil-in-water nanoemulsion templates we selected three cationic surfactants with different nature of hydrophilic head groups, i.e., double-headed (or so-called dicephalic-type) N,N-bis[3,3′(trimethylammonio)propyl]dodecanamide dimethylsulfate (C₁₂(TAPAMS)₂), bulky saccharide-derived 2-(dodecyldimethylammonio)ethylglucoheptonamide bromide (D₂GHA-12) and a classic dodecyltrimethylammonium bromide (DTABr) for comparison. The polyelectrolytes were the following: polyanion of poly(sodium 4-styrenesulfonate) (PSS) and polycation of poly(diallyldimethylammonium chloride) (PDADMAC). The in vitro release profile features, studied spectrophotometrically, were interpreted in the framework of diffusion-controlled processes and stability of the first interfacial PE–surfactant complex. Accordingly, the multicharge and bulky structure of the surfactant are found to be the most desirable factors for fabrication of long sustained and stable nanocapsules encapsulating a hydrophobic active substance.

In the present contribution, we demonstrate a new approach for functionalization of colloidal nanomaterial consisting of phosphatidylcholine/cholesterol-based vesicular systems modified by FDA-approved biocompatible components, i.e., sodium cholate hydrate acting as a biosurfactant and Pluronic P123—a symmetric triblock copolymer comprising poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) blocks Eight novel bilosome formulations were prepared using the thin-film hydration method followed by sonication and extrusion in combination with homogenization technique. The optimization studies involving the influence of the preparation technique on the nanocarrier size (dynamic light scattering), charge (electrophoretic light scattering), morphology (transmission electron microscopy) and kinetic stability (backscattering profiles) revealed the most promising candidate for the co-loading of model active compounds of various solubility; namely, hydrophilic methylene blue and hydrophobic curcumin. The studies of the hybrid cargo encapsulation efficiency (UV-Vis spectroscopy) exhibited significant potential of the formulated bilosomes in further biomedical and pharmaceutical applications, including drug delivery, anticancer treatment or diagnostics.

In recent years, lipid bicontinuous cubic liquid-crystalline nanoparticles known as cubosomes have been under investigation because of their favorable properties as drug nanocarriers useful for anticancer treatments. Herein, we present organic/inorganic hybrid, theranostic cubosomes stabilized in water with a shell of alternate layers of chitosan, single strand DNA (model genetic material for potential gene therapy), and folic acid–chitosan conjugate (the outmost layer), coencapsulating up-converting Er³⁺ and Yb³⁺ codoped NaYF₄ nanoparticles and daunorubicin. The latter acts as a chemotherapeutic drug of photosensitizing activity, while up-converting nanoparticles serve as energy harvester and diagnostic agent. Cellular uptake and NIR-induced photodynamic therapy were evaluated in vitro against human skin melanoma (MeWo) and ovarian (SKOV-3) cancer cells. Results evidenced the preferential uptake of the theranostic cubosomes in SKOV-3 cells in comparison to uptake in MeWo cells, and this effect was enhanced by the folic acid functionalization of the cubosomes surface. Nanocarriers coloaded with the hybrid fluorophores exhibited a superior NIR-induced photodynamic activity, also confirmed by the improved mitochondrial activity and the most affecting f-actin fibers of cytoskeleton. Similar results, but with higher photocytotoxicity, were detected when folic acid-functionalized cubosomes were incubated with SKOV-3 cells. Taken on the whole, these results prove these hybrid cubosomes are good candidates for the photodynamic treatment of tumor lesions.